Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Immunoconjugates × Clear all

NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Active not recruiting

Prostatic Neoplasms